Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Lipatnikova

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Brain & Spine|January 23, 2023
Meningioma classification by immunohistochemistry: A replicability studyOlivia Näslund, Anna Lipatnikova, Anna Dénes, et al.
Brain Pathology (Zurich, Switzerland)|January 3, 2024
Refinement of prognostication for IDH-mutant astrocytomas using DNA methylation-based classificationTeresia Kling, Sandra Ferreyra Vega, Medha Suman, et al.
Journal of Neuro-Oncology|May 20, 2025
CDKN2A/B status versus morphology in diagnosing WHO grade 4 IDH-mutated astrocytomas: what is the clinical relevance?Anna Lipatnikova, Teresia Kling, Anna Dénes, et al.
Neuro-Oncology Advances|May 11, 2026
Hemizygous deletion of <i>CDKN2A/B</i> in <i>IDH</i>-mutated glioma: Prognostic impact when adjusting for clinical factorsAnna Lipatnikova, Franziska M Ippen, Anna Dénes, et al.
Brain & Spine|January 15, 2026
Asleep motor mapping in resected low-grade gliomas -a population based multicenter studySophia M Leiss, Margret Jensdottir, Ole Solheim, et al.
Journal of Neurosurgery|March 13, 2026
Epidemiology of ischemic lesions after diffuse low-grade glioma resection: a Scandinavian multicenter studyTora Dunås, Margret Jensdottir, Ole Solheim, et al.
Brain Communications|October 13, 2025
Unravelling differences and hallmarks in suspected diffuse low-grade gliomas: a multicentre database studyFrancesco Latini, Markus Fahlström, Alice Neimantaite, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Brain & Spine|January 23, 2023
Meningioma classification by immunohistochemistry: A replicability studyOlivia Näslund, Anna Lipatnikova, Anna Dénes, et al.
Brain Pathology (Zurich, Switzerland)|January 3, 2024
Refinement of prognostication for IDH-mutant astrocytomas using DNA methylation-based classificationTeresia Kling, Sandra Ferreyra Vega, Medha Suman, et al.
Journal of Neuro-Oncology|May 20, 2025
CDKN2A/B status versus morphology in diagnosing WHO grade 4 IDH-mutated astrocytomas: what is the clinical relevance?Anna Lipatnikova, Teresia Kling, Anna Dénes, et al.
Neuro-Oncology Advances|May 11, 2026
Hemizygous deletion of <i>CDKN2A/B</i> in <i>IDH</i>-mutated glioma: Prognostic impact when adjusting for clinical factorsAnna Lipatnikova, Franziska M Ippen, Anna Dénes, et al.
Brain & Spine|January 15, 2026
Asleep motor mapping in resected low-grade gliomas -a population based multicenter studySophia M Leiss, Margret Jensdottir, Ole Solheim, et al.
Journal of Neurosurgery|March 13, 2026
Epidemiology of ischemic lesions after diffuse low-grade glioma resection: a Scandinavian multicenter studyTora Dunås, Margret Jensdottir, Ole Solheim, et al.
Brain Communications|October 13, 2025
Unravelling differences and hallmarks in suspected diffuse low-grade gliomas: a multicentre database studyFrancesco Latini, Markus Fahlström, Alice Neimantaite, et al.
Pageof 1